Astrana Health, Inc.ASTH

Astrana Health, Inc. (ASTH) has released its latest 8-K filing, revealing a strong quarter with $965.1 million in revenue for the period ending March 31, 2026. The company’s net income attributable to the parent stood at $14.4 million, with operating income coming in at $28.5 million. These figures paint a picture of a company that’s not just surviving, but thriving in the healthcare sector.

Astrana Health is a physician-led value-based care platform that’s committed to improving outcomes for patients and providers. The company has strategically built immediate and urgent care centers to provide on-demand, convenient, and high-quality healthcare services. This focus on expanding its physician enablement platform is clearly paying off, as evidenced by the company’s strong financial performance.

Looking at the filing, we see that Astrana Health has $478.4 million in cash and cash equivalents, which is a significant war chest for a company of its size. The company’s assets total $2.36 billion, with liabilities at $1.78 billion, giving it a solid equity base of $800.3 million. The company also reported net cash provided by operating activities of $68.1 million for the quarter, indicating a healthy cash flow situation.

For those looking to dive deeper into the company’s financials, the SEC EDGAR filings provide a wealth of information. The latest 8-K and 10-Q filings offer a comprehensive look at the company’s performance and financial health. The TradingView chart for ASTH also provides a visual representation of the company’s stock performance, which can be a useful tool for investors.

While the company’s financials are strong, there are always risks to consider. The healthcare sector is highly regulated and subject to political and economic pressures. also, the company’s growth strategy relies heavily on expanding its physician enablement platform, which comes with its own set of challenges and risks.